Tango Therapeutics President, R&D Crystal Adam disposes of 27,000 common shares worth $603,909 - TNGX News | RalliesTango Therapeutics President, R&D Crystal Adam disposes of 27,000 common shares worth $603,909
T
TNGX• Insider sale after option exercise
- Tango Therapeutics President, R&D Crystal Adam sold 27,000 common shares on Sep. 1 at USD 22.37.
- Sale followed the exercise of 27,000 stock options at USD 5.2.
- Directly held common shares fell to 115,743.
- Stock options held rose to 260,040 following the transaction.
MRNA
•
